The device kit developed by Final Frontier, called DxtER, uses non-invasive sensors that collect data from the user and combines that with an AI frontloaded with information in the field of clinical emergency medicine to come with a diagnosis. The device currently operates on an iPad tablet, but future versions should work equally fine on a smartphone as well. The device, ideally, would allow patients to then send their readings to their doctors so they could collaborate on their health care.

In the final head-to-head competition, the devices were told to reliably diagnose 12 medical conditions such as diabetes and Hepatitis A, as well as the absence of disease. They also had to measure five vital health signs, such as blood pressure. Neither team achieved perfect scores when it came to diagnosing and accuracy, but both surpassed the benchmarks for “user experience.”

According to an interview Harris held with the Washington Post, DxtER can diagnose up to 34 medical conditions in its present design. The device developed by Dynamical Biomarkers could reach up to 50, team leader and Harvard Medical School professor Chung-Kang Peng, told the Post, given it surpasses the five-pound weight limit imposed by the competition guidelines.